Bioadaptives (BDPT) Cash from Operations (2016 - 2025)
Bioadaptives' Cash from Operations history spans 7 years, with the latest figure at 155828.0 for Q4 2025.
- On a quarterly basis, Cash from Operations fell 54.99% to 155828.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 516025.0, a 106.81% decrease, with the full-year FY2025 number at 516025.0, down 106.81% from a year prior.
- Cash from Operations hit 155828.0 in Q4 2025 for Bioadaptives, down from 151309.0 in the prior quarter.
- Over the last five years, Cash from Operations for BDPT hit a ceiling of 19461.0 in Q1 2023 and a floor of 155828.0 in Q4 2025.
- Historically, Cash from Operations has averaged 68761.25 across 5 years, with a median of 58614.0 in 2021.
- Biggest five-year swings in Cash from Operations: tumbled 258.98% in 2021 and later skyrocketed 68.18% in 2023.
- Tracing BDPT's Cash from Operations over 5 years: stood at 35403.0 in 2021, then increased by 22.31% to 27504.0 in 2022, then crashed by 231.94% to 91296.0 in 2023, then fell by 10.12% to 100538.0 in 2024, then tumbled by 54.99% to 155828.0 in 2025.
- Business Quant data shows Cash from Operations for BDPT at 155828.0 in Q4 2025, 151309.0 in Q3 2025, and 110982.0 in Q2 2025.